Lan Hongxiang, Liu Yong, Bell Michal I, Gurevich Vsevolod V, Neve Kim A
Department of Physiology & Pharmacology, Oregon Health & Science University, Portland, Oregon, USA.
Mol Pharmacol. 2009 Jan;75(1):113-23. doi: 10.1124/mol.108.050534. Epub 2008 Sep 22.
Arrestins mediate G protein-coupled receptor desensitization, internalization, and signaling. Dopamine D(2) and D(3) receptors have similar structures but distinct characteristics of interaction with arrestins. The goals of this study were to compare arrestin-binding determinants in D(2) and D(3) receptors other than phosphorylation sites and to create a D(2) receptor that is deficient in arrestin binding. We first assessed the ability of purified arrestins to bind to glutathione transferase (GST) fusion proteins containing the receptor third intracellular loops (IC3). Arrestin3 bound to IC3 of both D(2) and D(3) receptors, with the affinity and localization of the binding site indistinguishable between the receptor subtypes. Mutagenesis of the GST-IC3 fusion proteins identified an important determinant of the binding of arrestin3 in the N-terminal region of IC3. Alanine mutations of this determinant (IYIV212-215) in the full-length D(2) receptor generated a signaling-biased receptor with intact ligand binding and G-protein coupling and activation, but deficient in receptor-mediated arrestin3 translocation to the membrane, agonist-induced receptor internalization, and agonist-induced desensitization in human embryonic kidney 293 cells. This mutation also decreased arrestin-dependent activation of extracellular signal-regulated kinases. The finding that nonphosphorylated D(2)-IC3 and D(3)-IC3 have similar affinity for arrestin is consistent with previous suggestions that the differential effects of D(2) and D(3) receptor activation on membrane translocation of arrestin and receptor internalization are due, at least in part, to differential phosphorylation of the receptors. In addition, these results imply that the sequence IYIV212-215 at the N terminus of IC3 of the D(2) receptor is a key element of the arrestin binding site.
抑制蛋白介导G蛋白偶联受体脱敏、内化及信号转导。多巴胺D2和D3受体结构相似,但与抑制蛋白相互作用的特征不同。本研究的目的是比较D2和D3受体中除磷酸化位点外的抑制蛋白结合决定因素,并构建一种抑制蛋白结合缺陷的D2受体。我们首先评估了纯化的抑制蛋白与含有受体第三细胞内环(IC3)的谷胱甘肽S-转移酶(GST)融合蛋白的结合能力。抑制蛋白3与D2和D3受体的IC3结合,结合位点的亲和力和定位在受体亚型之间无明显差异。对GST-IC3融合蛋白进行诱变,确定了IC3 N端区域中抑制蛋白3结合的一个重要决定因素。全长D2受体中该决定因素(IYIV212-215)的丙氨酸突变产生了一种信号偏向性受体,其配体结合、G蛋白偶联及激活功能完整,但在人胚肾293细胞中,受体介导的抑制蛋白3向膜的转位、激动剂诱导的受体内化及激动剂诱导的脱敏功能缺陷。该突变还降低了细胞外信号调节激酶的抑制蛋白依赖性激活。非磷酸化的D2-IC3和D3-IC3对抑制蛋白具有相似亲和力这一发现,与之前关于D2和D3受体激活对抑制蛋白膜转位和受体内化的不同影响至少部分归因于受体不同磷酸化的观点一致。此外,这些结果表明,D2受体IC3 N端的序列IYIV212-215是抑制蛋白结合位点的关键元件。